08Aug
FDA Releases New Warning Letter on Human and Animal Hemp CBD Products
On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the...
By:
Miller & Martin PLLC
Related
Draft Bearer Certificates (Collective Investment Schemes) Regulations 2020 - A draft version of the...
Read More >
Financial institutions M&A sector trends: payments — H2 2019 and outlook for 2020. Megadeals, incl...
Read More >
On June 13, 2019, the Departments of Treasury, Labor, and Health and Human Services issued final reg...
Read More >
New York has become the most progressive State in the nation when it comes to protecting workers aga...
Read More >
2019 brought continuing changes to employment law issues affecting the health care industry. The fol...
Read More >
HEADLINES - In 2019, European take-private deals backed by private equity reached €34.5 billion ov...
Read More >